A NEW TRIPLE-ACTION SERUM
with Hyaluronic Acid, Vitamin C Niacinamide and Ferulic Acid act on key signs of aging.
Discover a new technological breakthrough, Rénergie H.C.F Triple Serum. Patented until 2035, Rénergie H.C.F. Triple Serum masterfully concentrates into one radically caring triple dose Hyaluronic Acid, C Niacinamide Vitamins and Ferulic Acid. Each powerful alone, yet impossible to combine in one single formula, they now freshly fuse into a high performance anti-aging concentrate.
WHAT DOES IT DO?
TRIPLE ACTION ANTI-AGING
1. SKIN FIRMNESS AND QUALITY REPLUMPED
2. PROGRESSIVE WRINKLE CORRECTION
3. SKIN TONE TRIPLE CORRECTION
WHAT MAKES IT DIFFERENT?
With its unique triple-chamber packaging and masterful combination of ingredients, this revolutionary anti-aging serum strikes the perfect balance between being highly efficacious while also providing a gentle and caring experience for the skin. It is the first triple-dose serum of its kind on the market. A highly effective, yet radically caring new kind of gesture. In a unparalleled study, 9 out of 10 women using luxury serums confirmed they would choose Rénergie H.C.F. Triple Serum over or additionally to their regular serum.
WHAT ELSE YOU NEED TO KNOW?
IMPROVED SKIN VOLUMETRY AND QUALITY
37% more tonicity in one triple dose**
• Week 1: Skin feels replumped and rejuvenated***
• Week 2: Facial traits and neck look and feel retightened***
• Week 8: Clinically-proven efficacy on sagging skin*
FAST AND PROGRESSIVE LINE AND WRINKLE CORRECTION*
• Week 2: Fine lines are globally and visibly replumped
• Week 4: Correction accelerates with 26.3% measured smoothness
• Week 8: Wrinkles show significant correction
UNEVEN SKIN TONE TRIPLE CORRECTION*
• Lighter: Uneven skin tone is less visible as early as 4 weeks.
• Fewer: Count of discolorations is significantly reduced in 8 weeks
• Smaller: Size of spots, including persisting ones, is reduced in 8 weeks.
Tested under dermatological control. All skin types - even sensitive skin.
*Clinical measure, 58 women
**Instrumental test.
*** Self-assessment, 58 women
